The verified answer
As of Sep 2026, DEPLOY verifies MicroPort Scientific Corporation: 1 model. 1 source back the record.
CategorySurgical robots
Overview
Shanghai-based multinational medical device company founded in 1998 by Zhaohua Chang, listed on the Hong Kong Stock Exchange (00853.HK). MicroPort develops cardiovascular, orthopedic, neurovascular, and cardiac rhythm management devices, and is a pioneer in surgical robotics through its subsidiary MicroPort MedBot (02252.HK). The company's SkyWalker™ orthopedic surgical robot was the first Chinese-developed surgical robot to receive FDA, CE, and NMPA approval, with over 1,100 total knee arthroplasty procedures completed across hospitals in China, the United States, and Europe.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
CEO
Employees
Revenue
Products
Surgical Robot
Subsidiaries
JVs
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →MicroPort Scientific Corporation on the deployment map
View the global mapMicroPort Scientific Corporation has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for MicroPort Scientific Corporation on the DEPLOY record yet. Track MicroPort Scientific Corporation to know the moment the first one is verified.
Current leadership (1)
- Zhaohua Chang CEOreported, not verified
Safety record
No incidents on record for MicroPort Scientific Corporation.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
MicroPort Scientific Corporation in third-party press
MicroPort Scientific Corporation: Significant Improvement in 2024 First Half Performance by 63.1%
SkyWalker® Orthopedic Surgical Robot Global Surgical Volume Exceeds a Thousand Cases
MedBot & Robocath Announce Execution of Definitive Agreements for Vascular Robotics JV
Financial state
- Reporting basis
- private_reported
- Revenue disclosed
- $1031100000 (private_reported)
- Lifecycle stage
- mature
- Counterparty risk class
- elevated
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
Sources (1)
Common questions
What is MicroPort Scientific Corporation?
What does MicroPort Scientific Corporation make?
Is MicroPort Scientific Corporation publicly traded?
Who is the CEO of MicroPort Scientific Corporation?
How can I invest in MicroPort Scientific Corporation?
Where is MicroPort Scientific Corporation headquartered?
Who owns MicroPort Scientific Corporation?
Where does MicroPort Scientific Corporation operate robots?
Is MicroPort Scientific Corporation a top robotics company?
Is MicroPort Scientific Corporation safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-30
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-30
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for MicroPort Scientific Corporation.In the press
Recent coverage mentioning MicroPort Scientific Corporation from third-party publications. Automatically surfaced; not part of the verified registry record.
MicroPort Scientific Corporation: Significant Improvement in 2024 First Half Performance by 63.1%
MicroPort reported H1 2024 revenue of US$558.7M, up 17% YoY, with losses narrowed by 63.1% as the company focused on core businesses and cost optimization.
SkyWalker® Orthopedic Surgical Robot Global Surgical Volume Exceeds a Thousand Cases
SkyWalker robot surpassed 1,100 cumulative TKA surgeries globally, with clinical applications in nearly 70 hospitals across China, the US, and Europe.
MedBot & Robocath Announce Execution of Definitive Agreements for Vascular Robotics JV
MicroPort's MedBot division and Robocath announced a joint venture for vascular robotics in the China territory.
MicroPort MedBot SkyWalker™ Orthopedic Surgical Robot Gets CE Marking
SkyWalker became the first Chinese orthopedic surgical robot to receive CE marking in the EU, completing regulatory approvals across China, US, and Europe.
MicroPort MedBot NaviBot Announces First Clinical Use of Skywalker™ Surgical Robot for Total Knee Procedures in the United States
MicroPort MedBot completed the first US clinical use of the SkyWalker robotic system for total knee arthroplasty in Foxborough, MA.
Machine-readable surfaces
- Markdown mirror: /companies/microport-scientific.md
- RSS feed: /companies/microport-scientific/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/14743927-bcca-4491-a519-3c572491e98d
- Revision history: /companies/microport-scientific/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
Here at MicroPort we and our employees believe that the mastery of small details is vital in developing the best medical technologies for our patients and surge
By restoring a patient’s natural kinematics and offering a simple, reproducible surgical technique, the Evolution® medial-pivot knee system help surgeons raise
Surgical Robotics Expert Steve Bell joins Kash Ikram (head of Europe) for a sit visit to see the headquarters of MicroPort - their company MedBot and dig deep i
#MicroPort MedBot™ shapes super-intelligent surgery, leading 6 subsectors and pioneering #MedTech for #BetterAndLongerLives. Learn more : https://microport.com
Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot™, 02252.HK,) covering 5 Golden tracks of surgical robot including Laparoscopic Solution、Orthopedi
When we visited Kashif Ikram, Vice President of Commercial Surgical Robotics for Europe at MicroPort MedBot, we learnt about the Toumai® System and the technolo
Introduction to the workshop sponsor MicroPort MedBot® made by Dr. Linfei Xiong 📹 Workshop website: https://sites.google.com/view/rolemap-iros2022
We visited Kashif Ikram, Vice President of Commercial Surgical Robotics for Europe at MicroPort MedBot, to learn more about the Toumai® System. The Toumai® En
#MicroPort MedBot™ shapes super-intelligent surgery, leading 6 subsectors and pioneering #MedTech for #BetterAndLongerLives. Learn more: https://microport.com/h
Visit Microport , Medbot on the Metaverse and book your training session https://www.spatial.io/s/Metaverse-Surgical-Hospital-6365ac571cc51b0001463a1c?share=3
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
MicroPort Scientific Corporation draws attention at the 40th percentile but verifies reality at the insufficient-data level among surgical robots.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 3, 2026